Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen C Nelson

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Journal of Bacteriology|March 6, 2003
Molecular analysis of the multiple GroEL proteins of ChlamydiaeKaruna P Karunakaran, Yasuyuki Noguchi, Timothy D Read, et al.
Molecular Cancer Research : MCR|October 12, 2011
Clusterin is a critical downstream mediator of stress-induced YB-1 transactivation in prostate cancerMasaki Shiota, Amina Zoubeidi, Masafumi Kumano, et al.
Endocrine-Related Cancer|October 28, 2020
Adiponectin receptor activation inhibits prostate cancer xenograft growthLisa K Philp, Anja Rockstroh, Melanie Lehman, et al.
The Prostate|September 1, 2017
Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancerCarolina Soekmadji, Niall M Corcoran, Irina Oleinikova, et al.
The Biochemical Journal|July 17, 2003
Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid systemLatif A Wafa, Helen Cheng, Mira A Rao, et al.
BMC Genomics|March 14, 2015
RNASeqBrowser: a genome browser for simultaneous visualization of raw strand specific RNAseq reads and UCSC genome browser custom tracksJiyuan An, John Lai, David L A Wood, et al.
Current Cancer Drug Targets|April 18, 2015
Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate CancerRyan Stuchbery, Natalie J Kurganovs, Patrick J McCoy, et al.
BMC Cancer|April 18, 2015
The tumour-promoting receptor tyrosine kinase, EphB4, regulates expression of integrin-β8 in prostate cancer cellsInga Mertens-Walker, Bruno C Fernandini, Mohanan S N Maharaj, et al.
The Prostate|March 26, 2004
YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activityPepita Giménez-Bonafé, Matthew N Fedoruk, Tanis G Whitmore, et al.
Journal of Natural Products|April 28, 2016
Bioactive Dihydro-β-agarofuran Sesquiterpenoids from the Australian Rainforest Plant Maytenus bilocularisMario Wibowo, Claire Levrier, Martin C Sadowski, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Journal of Bacteriology|March 6, 2003
Molecular analysis of the multiple GroEL proteins of ChlamydiaeKaruna P Karunakaran, Yasuyuki Noguchi, Timothy D Read, et al.
Molecular Cancer Research : MCR|October 12, 2011
Clusterin is a critical downstream mediator of stress-induced YB-1 transactivation in prostate cancerMasaki Shiota, Amina Zoubeidi, Masafumi Kumano, et al.
Endocrine-Related Cancer|October 28, 2020
Adiponectin receptor activation inhibits prostate cancer xenograft growthLisa K Philp, Anja Rockstroh, Melanie Lehman, et al.
The Prostate|September 1, 2017
Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancerCarolina Soekmadji, Niall M Corcoran, Irina Oleinikova, et al.
The Biochemical Journal|July 17, 2003
Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid systemLatif A Wafa, Helen Cheng, Mira A Rao, et al.
BMC Genomics|March 14, 2015
RNASeqBrowser: a genome browser for simultaneous visualization of raw strand specific RNAseq reads and UCSC genome browser custom tracksJiyuan An, John Lai, David L A Wood, et al.
Current Cancer Drug Targets|April 18, 2015
Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate CancerRyan Stuchbery, Natalie J Kurganovs, Patrick J McCoy, et al.
BMC Cancer|April 18, 2015
The tumour-promoting receptor tyrosine kinase, EphB4, regulates expression of integrin-β8 in prostate cancer cellsInga Mertens-Walker, Bruno C Fernandini, Mohanan S N Maharaj, et al.
The Prostate|March 26, 2004
YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activityPepita Giménez-Bonafé, Matthew N Fedoruk, Tanis G Whitmore, et al.
Journal of Natural Products|April 28, 2016
Bioactive Dihydro-β-agarofuran Sesquiterpenoids from the Australian Rainforest Plant Maytenus bilocularisMario Wibowo, Claire Levrier, Martin C Sadowski, et al.
Pageof 12